A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide 11Ms. Clineschmidt, Dr. Adamsons, Dr. Snyder, and Dr. Reines are employees of Merck & Co., Inc., the manufacturer of the dorzolamide-timolol combination. The other authors have no proprietary interest in the dorzolamide-timolol combination or in Merck.
Authors:
- Robert D WilliamsRWRobert D Williams
- 1 October 1998
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 105 (10) , 1952-1959
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The Efficacy and Safety of Dorzolamide as Adjunctive Therapy to Timolol Maleate Gellan Solution in Patients with Elevated Intraocular PressureJournal of Glaucoma, 1998
- Dorzolamide versus pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily lifeClinical Therapeutics, 1996
- The Use of Dorzolamide and Pilocarpine as Adjunctive Therapy to Timolol in Patients with Elevated Intraocular PressureOphthalmology, 1996
- A Double-Masked, Randomized 1-Year Study Comparing Dorzolamide (Trusopt), Timolol, and BetaxololArchives of Ophthalmology (1950), 1995
- Acetazolamide but not timolol lowers aqueous humor flow in sleeping humansGraefe's Archive for Clinical and Experimental Ophthalmology, 1992
- The effect of prescribed daily dose frequency on patient medication complianceArchives of internal medicine (1960), 1990
- Timolol-Pilocarpine Combined vs Timolol and Pilocarpine Given SeparatelyAmerican Journal of Ophthalmology, 1989
- Compliance with Topical Pilocarpine TreatmentAmerican Journal of Ophthalmology, 1986